Transgenically produced decorin

Details for Australian Patent Application No. 2001259465 (hide)

Owner GTC Biotherapeutics, Inc. Integra LifeSciences Corp

Inventors Meade, Harry M; Pierschbacher, Michael

Agent Davies Collison Cave

Pub. Number AU-B-2001259465

PCT Pub. Number WO01/85192

Priority 60201932 05.05.00 US

Filing date 4 May 2001

Wipo publication date 20 November 2001

Acceptance publication date 7 December 2006

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

13 March 2003 Change of Name(s) of Applicant(s), Section 104

  Genzyme Transgenics Corporation The name of the applicant has been changed to GTC Therapeutics, Inc.

7 December 2006 Application Accepted

  Published as AU-B-2001259465

5 April 2007 Standard Patent Sealed

3 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001259466

2001259464